Published in J Palliat Med on May 01, 2010
A practical and ethical solution to the opioid scheduling conundrum. J Pain Res (2013) 0.84
Ensuring safe access to medication for palliative care while preventing prescription drug abuse: innovations for American inner cities, rural areas, and communities overwhelmed by addiction. Risk Manag Healthc Policy (2011) 0.83
Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain (2009) 9.36
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78
Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain (2007) 6.98
Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol (2013) 5.07
Critical issues on opioids in chronic non-cancer pain: an epidemiological study. Pain (2006) 4.96
Availability and integration of palliative care at US cancer centers. JAMA (2010) 4.51
Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA (2003) 4.25
Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. J Clin Oncol (2009) 3.36
Opioid rotation in the management of refractory cancer pain. J Clin Oncol (2002) 2.78
Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology (2003) 2.62
Supportive versus palliative care: what's in a name?: a survey of medical oncologists and midlevel providers at a comprehensive cancer center. Cancer (2009) 2.58
Medical oncologists' attitudes and practice in cancer pain management: a national survey. J Clin Oncol (2011) 2.32
Ensuring quality cancer care: a follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer (2011) 2.15
Dehydration in cancer patients: to treat or not to treat. J Support Oncol (2004) 2.15
The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia. J Palliat Med (2013) 2.00
Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer. Cancer (2010) 1.97
Establishing "best practices" for opioid rotation: conclusions of an expert panel. J Pain Symptom Manage (2009) 1.96
Delirium in advanced cancer patients. Palliat Med (2004) 1.92
Interval between first palliative care consult and death in patients diagnosed with advanced cancer at a comprehensive cancer center. J Palliat Med (2008) 1.76
Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain (2006) 1.72
Breakthrough pain characteristics and syndromes in patients with cancer pain. An international survey. Palliat Med (2004) 1.71
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy. Cytokine (2004) 1.70
Opioid rotation: the science and the limitations of the equianalgesic dose table. J Pain Symptom Manage (2009) 1.70
Interval between palliative care referral and death among patients treated at a comprehensive cancer center. J Palliat Med (2005) 1.67
Symptom distress and quality of life in patients with advanced congestive heart failure. J Pain Symptom Manage (2008) 1.66
Patient-physician communication about code status preferences: a randomized controlled trial. Cancer (2013) 1.66
NCCN clinical practice guidelines in oncology: palliative care. J Natl Compr Canc Netw (2009) 1.66
A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group. J Palliat Med (2010) 1.64
Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain (2006) 1.61
Association between a name change from palliative to supportive care and the timing of patient referrals at a comprehensive cancer center. Oncologist (2011) 1.61
Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol (2013) 1.59
An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer (2010) 1.59
The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study. J Palliat Med (2010) 1.57
Palliative management of fatigue at the close of life: "it feels like my body is just worn out". JAMA (2007) 1.57
Bedside clinical signs associated with impending death in patients with advanced cancer: preliminary findings of a prospective, longitudinal cohort study. Cancer (2015) 1.56
Palliative care inpatient service in a comprehensive cancer center: clinical and financial outcomes. J Clin Oncol (2004) 1.55
Inpatient rehabilitation improved functional status in asthenic patients with solid and hematologic malignancies. Am J Phys Med Rehabil (2011) 1.54
Impact of timing and setting of palliative care referral on quality of end-of-life care in cancer patients. Cancer (2014) 1.49
Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center. J Palliat Med (2010) 1.48
Cancer patients' perceptions regarding the value of the physical examination: a survey study. Cancer (2014) 1.44
A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther (2004) 1.40
Access to care for chronic pain: racial and ethnic differences. J Pain (2005) 1.39
The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report. J Palliat Med (2014) 1.39
Pain management by primary care physicians, pain physicians, chiropractors, and acupuncturists: a national survey. South Med J (2010) 1.38
Impact of a palliative care consultation team on cancer-related symptoms in advanced cancer patients referred to an outpatient supportive care clinic. J Pain Symptom Manage (2010) 1.37
The measurement of symptoms in young children with cancer: the validation of the Memorial Symptom Assessment Scale in children aged 7-12. J Pain Symptom Manage (2002) 1.36
Access to palliative care among patients treated at a comprehensive cancer center. Oncologist (2012) 1.34
Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol (2008) 1.32
Characteristics, findings, and outcomes of palliative care inpatient consultations at a comprehensive cancer center. J Palliat Med (2007) 1.32
Quantity, design, and scope of the palliative oncology literature. Oncologist (2011) 1.32
Prevalence and characteristics of chronic pain in patients admitted to an outpatient drug and alcohol treatment program. Pain Med (2008) 1.31
Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease. J Pain Symptom Manage (2009) 1.31
The lack of standard definitions in the supportive and palliative oncology literature. J Pain Symptom Manage (2011) 1.30
Pain and emotional distress in leukemia patients at diagnosis. Leuk Res (2009) 1.26
Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer (2004) 1.25
The accuracy of probabilistic versus temporal clinician prediction of survival for patients with advanced cancer: a preliminary report. Oncologist (2011) 1.24
A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician (2012) 1.24
Spirituality, religiosity, and spiritual pain in advanced cancer patients. J Pain Symptom Manage (2011) 1.23
Targeted agent use in cancer patients at the end of life. J Pain Symptom Manage (2012) 1.22
Symptom control in palliative care--Part II: cachexia/anorexia and fatigue. J Palliat Med (2006) 1.22
Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother (2004) 1.22
Assessing hope at the end of life: validation of an experience of hope scale in advanced cancer patients. Palliat Support Care (2004) 1.20
Consensus guideline on parenteral methadone use in pain and palliative care. Palliat Support Care (2008) 1.20
Can this patient be discharged home? Factors associated with at-home death among patients with cancer. J Clin Oncol (2011) 1.20
Molecular epidemiology, cancer-related symptoms, and cytokines pathway. Lancet Oncol (2008) 1.19
Antineoplastic therapy use in patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center: a simultaneous care model. Cancer (2010) 1.19
Characteristics and correlates of dyspnea in patients with advanced cancer. J Palliat Med (2009) 1.18
A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patients. Eur J Cancer (2011) 1.17
Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med (2008) 1.17
Measurement of QTc in patients receiving chronic methadone therapy. J Pain Symptom Manage (2005) 1.15
Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. J Palliat Med (2008) 1.15
Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer (2014) 1.14
Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med (2007) 1.14
NOPPAIN: a nursing assistant-administered pain assessment instrument for use in dementia. Dement Geriatr Cogn Disord (2004) 1.14
Dose conversion and titration with a novel, once-daily, OROS osmotic technology, extended-release hydromorphone formulation in the treatment of chronic malignant or nonmalignant pain. J Pain Symptom Manage (2002) 1.13
Symptom distress, interventions, and outcomes of intensive care unit cancer patients referred to a palliative care consult team. Cancer (2009) 1.13
Symptom control in palliative care--Part III: dyspnea and delirium. J Palliat Med (2006) 1.13
Quality of life and survival prediction in terminal cancer patients: a multicenter study. Cancer (2004) 1.12
Switching from methadone to a different opioid: what is the equianalgesic dose ratio? J Palliat Med (2008) 1.12
Opioid switching: a systematic and critical review. Cancer Treat Rev (2006) 1.10
Dyspnea in hospitalized advanced cancer patients: subjective and physiologic correlates. J Palliat Med (2013) 1.10
Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel. J Pain Symptom Manage (2004) 1.10
The impact of palliative care consultation on symptom assessment, communication needs, and palliative interventions in pediatric patients with cancer. J Palliat Med (2009) 1.09
The assessment and management of delirium in cancer patients. Oncologist (2009) 1.08
Dual opioid therapy using methadone as a coanalgesic. Expert Opin Drug Saf (2014) 1.08
Adjuvant analgesics in cancer pain management. Oncologist (2004) 1.08
Botulinum toxin injection and phenol nerve block for reduction of end-of-life pain. J Palliat Med (2013) 1.08
Symptom control in palliative care--Part I: oncology as a paradigmatic example. J Palliat Med (2006) 1.08
Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients. Cancer (2011) 1.07
The Edmonton Symptom Assessment System as a screening tool for depression and anxiety. J Palliat Med (2006) 1.06
Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer (2008) 1.06
Concepts and definitions for "supportive care," "best supportive care," "palliative care," and "hospice care" in the published literature, dictionaries, and textbooks. Support Care Cancer (2012) 1.06
Cytokine genes and pain severity in lung cancer: exploring the influence of TNF-alpha-308 G/A IL6-174G/C and IL8-251T/A. Cancer Epidemiol Biomarkers Prev (2007) 1.05
Attitudes of terminally ill cancer patients about euthanasia and assisted suicide: predominance of psychosocial determinants and beliefs over symptom distress and subsequent survival. J Clin Oncol (2002) 1.05
Parents dying of cancer and their children. Palliat Support Care (2004) 1.04
Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug Alcohol Depend (2012) 1.03
Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer (2010) 1.03
Genetic and nongenetic covariates of pain severity in patients with adenocarcinoma of the pancreas: assessing the influence of cytokine genes. J Pain Symptom Manage (2009) 1.02